(Q34312866)

English

Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 August 2017

Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors (English)

1 reference

Europe PubMed Central

1 August 2017

Françoise Imbert-Bismut

1

object named as

Françoise Imbert-Bismut

0 references

Thierry Poynard

object named as

Thierry Poynard

10

0 references

Djamila Messous

2

object named as

Djamila Messous

1 reference

Europe PubMed Central

1 August 2017

Dominique Thabut

6

object named as

Dominique Thabut

1 reference

Europe PubMed Central

1 August 2017

5

object named as

Annie Piton

1 reference

Europe PubMed Central

1 August 2017

author name string

Françoise Imbert-Bismut

1

1 reference

Europe PubMed Central

1 August 2017

Vincent Thibault

3

1 reference

Europe PubMed Central

1 August 2017

Rob B Myers

4

1 reference

Europe PubMed Central

1 August 2017

Laure Devers

7

1 reference

Europe PubMed Central

1 August 2017

Bernard Hainque

8

1 reference

Europe PubMed Central

1 August 2017

Anne Mercadier

9

1 reference

Europe PubMed Central

1 August 2017

publication date

1 March 2004

1 reference

Europe PubMed Central

1 August 2017

Clinical Chemistry and Laboratory Medicine

1 reference

Europe PubMed Central

1 August 2017

42

1 reference

Europe PubMed Central

1 August 2017

323-333

1 reference

Europe PubMed Central

1 August 2017

3

1 reference

Europe PubMed Central

1 August 2017

Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF).

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.058

21 January 2018

Hepatic fibrosis: are any of the serum markers useful?

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.058

21 January 2018

Matrix metalloproteinase-9 and tissue inhibitors of matrix metalloproteinase-1 in plasma of patients co-infected with HCV and HIV.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.058

21 January 2018

Prothrombin index is an indirect marker of severe liver fibrosis

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.058

21 January 2018

Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.058

21 January 2018

Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.058

21 January 2018

Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus co-infected patients

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.058

21 January 2018

Rat hepatic stellate cell expression of alpha2-macroglobulin is a feature of cellular activation: implications for matrix remodelling in hepatic fibrosis.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.058

21 January 2018

Haptoglobin polymorphism and chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.058

21 January 2018

Increased levels of gammaGT suggest the presence of bile duct lesions in patients with chronic hepatitis C: absence of influence of HCV genotype, HCV-RNA serum levels, and HGV infection on this histological damage

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.058

21 January 2018

Modulation of gamma-glutamyltranspeptidase in normal rat hepatocytes in culture by cell density, epidermal growth factor and agents which alter cell differentiation

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.058

21 January 2018

Evaluation of abnormal liver-enzyme results in asymptomatic patients

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.058

21 January 2018

Guidelines for healthy weight

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.058

21 January 2018

The Measurement of Observer Agreement for Categorical Data

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.058

21 January 2018

A prospective assessment of the inter-laboratory variability of biochemical markers of fibrosis (FibroTest) and activity (ActiTest) in patients with chronic liver disease

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.058

21 January 2018

Effect of certified reference material 470 (CRM 470) on national quality assurance programs for serum proteins in Europe.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.058

21 January 2018

Protein standardization III: Method optimization basic principles for quantitative determination of human serum proteins on automated instruments based on turbidimetry or nephelometry.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.058

21 January 2018

Commutability of serum protein values: persisting bias among manufacturers using values assigned from the certified reference material 470 (CRM 470) in the United States.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.058

21 January 2018

Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.058

21 January 2018

Factors associated with serum alanine transaminase activity in healthy subjects: consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C. MULTIVIRC Group.

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.058

21 January 2018

Population frequency distributions of HDL, HDL(2), and HDL(3) cholesterol and apolipoproteins A-I and B in healthy men and women and associations with age, gender, hormonal status, and sex hormone use: the Stanford Five City Project

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2004.058

21 January 2018

Identifiers

10.1515/CCLM.2004.058

1 reference

Europe PubMed Central

1 August 2017

1 reference

Europe PubMed Central

1 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34312866&oldid=1857510343"